-+ 0.00%
-+ 0.00%
-+ 0.00%

Medicenna Therapeutics Q2 EPS $(0.04) Beats $(0.06) Estimate

Benzinga·11/17/2026 12:48:19
Listen to the news
Medicenna Therapeutics (TSX:MDNA) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.06) by 20 percent. This is a 33.33 percent increase over losses of $(0.06) per share from the same period last year.